Selected research
Industry Research
Enalaprilat Industry Research Report 2026
Market perspective
The global Enalaprilat market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Enalaprilat is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Enalaprilat is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Enalaprilat is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Enalaprilat include Balkan Pharmaceuticals, Cadila Pharmaceuticals, Hikma Pharmaceuticals, KRKA, Novartis(Hexal AG), SteriMax and Teva(Barr Pharmaceuticals), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Enalaprilat market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Enalaprilat Market by Company
Balkan Pharmaceuticals
Cadila Pharmaceuticals
Hikma Pharmaceuticals
KRKA
Novartis(Hexal AG)
SteriMax
Teva(Barr Pharmaceuticals)
Enalaprilat Segment by Type
1mL Vial
2mL Vial
Enalaprilat Segment by Application
Hospital
Pharmacy
Enalaprilat Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enalaprilat market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enalaprilat and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enalaprilat.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Enalaprilat manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Enalaprilat by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Enalaprilat in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mL Vial
- 2mL Vial
Applications
- Hospital
- Pharmacy
Companies covered
- Balkan Pharmaceuticals
- Cadila Pharmaceuticals
- Hikma Pharmaceuticals
- KRKA
- Novartis(Hexal AG)
- SteriMax
- Teva(Barr Pharmaceuticals)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Enalaprilat Market Size (2021-2032)
- 2.2.2 Global Enalaprilat Sales (2021-2032)
- 2.2.3 Global Enalaprilat Market Average Price (2021-2032)
- 2.3 Enalaprilat by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1mL Vial
- 2.3.3 2mL Vial
- 2.4 Enalaprilat by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Enalaprilat Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Enalaprilat Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Enalaprilat Revenue of Manufacturers (2021-2026)
- 3.4 Global Enalaprilat Average Price by Manufacturers (2021-2026)
- 3.5 Global Enalaprilat Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Enalaprilat, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Enalaprilat, Product Type & Application
- 3.8 Global Manufacturers of Enalaprilat, Established Date
- 3.9 Global Enalaprilat Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Balkan Pharmaceuticals
- 4.1.1 Balkan Pharmaceuticals Company Information
- 4.1.2 Balkan Pharmaceuticals Business Overview
- 4.1.3 Balkan Pharmaceuticals Enalaprilat Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Balkan Pharmaceuticals Enalaprilat Product Portfolio
- 4.1.5 Balkan Pharmaceuticals Recent Developments
- 4.2 Cadila Pharmaceuticals
- 4.2.1 Cadila Pharmaceuticals Company Information
- 4.2.2 Cadila Pharmaceuticals Business Overview
- 4.2.3 Cadila Pharmaceuticals Enalaprilat Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cadila Pharmaceuticals Enalaprilat Product Portfolio
- 4.2.5 Cadila Pharmaceuticals Recent Developments
- 4.3 Hikma Pharmaceuticals
- 4.3.1 Hikma Pharmaceuticals Company Information
- 4.3.2 Hikma Pharmaceuticals Business Overview
- 4.3.3 Hikma Pharmaceuticals Enalaprilat Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hikma Pharmaceuticals Enalaprilat Product Portfolio
- 4.3.5 Hikma Pharmaceuticals Recent Developments
- 4.4 KRKA
- 4.4.1 KRKA Company Information
- 4.4.2 KRKA Business Overview
- 4.4.3 KRKA Enalaprilat Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 KRKA Enalaprilat Product Portfolio
- 4.4.5 KRKA Recent Developments
- 4.5 Novartis(Hexal AG)
- 4.5.1 Novartis(Hexal AG) Company Information
- 4.5.2 Novartis(Hexal AG) Business Overview
- 4.5.3 Novartis(Hexal AG) Enalaprilat Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis(Hexal AG) Enalaprilat Product Portfolio
- 4.5.5 Novartis(Hexal AG) Recent Developments
- 4.6 SteriMax
- 4.6.1 SteriMax Company Information
- 4.6.2 SteriMax Business Overview
- 4.6.3 SteriMax Enalaprilat Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SteriMax Enalaprilat Product Portfolio
- 4.6.5 SteriMax Recent Developments
- 4.7 Teva(Barr Pharmaceuticals)
- 4.7.1 Teva(Barr Pharmaceuticals) Company Information
- 4.7.2 Teva(Barr Pharmaceuticals) Business Overview
- 4.7.3 Teva(Barr Pharmaceuticals) Enalaprilat Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teva(Barr Pharmaceuticals) Enalaprilat Product Portfolio
- 4.7.5 Teva(Barr Pharmaceuticals) Recent Developments
5 Global Enalaprilat Market Scenario by Region
- 5.1 Global Enalaprilat Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Enalaprilat Sales by Region: 2021-2032
- 5.2.1 Global Enalaprilat Sales by Region: 2021-2026
- 5.2.2 Global Enalaprilat Sales by Region: 2027-2032
- 5.3 Global Enalaprilat Revenue by Region: 2021-2032
- 5.3.1 Global Enalaprilat Revenue by Region: 2021-2026
- 5.3.2 Global Enalaprilat Revenue by Region: 2027-2032
- 5.4 North America Enalaprilat Market Facts & Figures by Country
- 5.4.1 North America Enalaprilat Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Enalaprilat Sales by Country (2021-2032)
- 5.4.3 North America Enalaprilat Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Enalaprilat Market Facts & Figures by Country
- 5.5.1 Europe Enalaprilat Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Enalaprilat Sales by Country (2021-2032)
- 5.5.3 Europe Enalaprilat Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Enalaprilat Market Facts & Figures by Country
- 5.6.1 Asia Pacific Enalaprilat Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Enalaprilat Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Enalaprilat Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Enalaprilat Market Facts & Figures by Country
- 5.7.1 South America Enalaprilat Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Enalaprilat Sales by Country (2021-2032)
- 5.7.3 South America Enalaprilat Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Enalaprilat Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Enalaprilat Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Enalaprilat Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Enalaprilat Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Enalaprilat Sales by Type (2021-2032)
- 6.1.1 Global Enalaprilat Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Enalaprilat Sales Market Share by Type (2021-2032)
- 6.2 Global Enalaprilat Revenue by Type (2021-2032)
- 6.2.1 Global Enalaprilat Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Enalaprilat Revenue Market Share by Type (2021-2032)
- 6.3 Global Enalaprilat Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Enalaprilat Sales by Application (2021-2032)
- 7.1.1 Global Enalaprilat Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Enalaprilat Sales Market Share by Application (2021-2032)
- 7.2 Global Enalaprilat Revenue by Application (2021-2032)
- 7.2.1 Global Enalaprilat Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Enalaprilat Revenue Market Share by Application (2021-2032)
- 7.3 Global Enalaprilat Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Enalaprilat Value Chain Analysis
- 8.1.1 Enalaprilat Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Enalaprilat Production Mode & Process
- 8.2 Enalaprilat Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Enalaprilat Distributors
- 8.2.3 Enalaprilat Customers
9 Global Enalaprilat Analyzing Market Dynamics
- 9.1 Enalaprilat Industry Trends
- 9.2 Enalaprilat Industry Drivers
- 9.3 Enalaprilat Industry Opportunities and Challenges
- 9.4 Enalaprilat Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst